Occudo Quantitative Strategies LP Ab Cellera Biologics Inc. Transaction History

Occudo Quantitative Strategies LP

  • $501 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$4.29 - $5.97 $58,472 - $81,371
13,630 New
13,630 $61,000
Q3 2022

Nov 14, 2022
BUY
$9.2 - $13.68 $630,770 - $937,928
68,562 Added 72.69%
162,885 $1.61 Million
Q2 2022

Aug 15, 2022
SELL
$5.72 - $10.65 $128,385 - $239,039
-22,445 Reduced 19.22%
94,323 $1.01 Million
Q1 2022

May 16, 2022
BUY
$7.46 - $14.14 $670,661 - $1.27 Million
89,901 Added 334.61%
116,768 $1.14 Million
Q4 2021

Feb 14, 2022
BUY
$12.99 - $17.73 $349,002 - $476,351
26,867 New
26,867 $384,000

Others Institutions Holding ABCL

# of Institutions
155
Shares Held
109M
Call Options Held
153K
Put Options Held
194K
View Full List

About AbCellera Biologics Inc.

ABCL Quotes by TradingView
  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $807M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email